Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraphene Nanochem Regulatory News (GRPH)

  • There is currently no data for GRPH

Re Contract

10 Dec 2009 14:27

RNS Number : 9323D
Biofutures International plc
10 December 2009
 



Biofutures International plc

("Biofutures" or the "Company")

Process System Contract

10 December 2009 

Following the announcement on 20 February 2009Biofutures is now pleased to announce that its wholly owned subsidiary, Zurex Corporation Sdn. Bhd. ("Zurex"), has today entered into a contract (the "Contract") with WS Bioengineering Pte. Ltd. ("WS Bio") for the supply of a complete physical refining plant system capable of refining crude palm oil into refined bleached and deodorized palm oil (the "Refining System") for the 200,000 metric tonne per annum palm oil refinery plant (the "Refinery") currently being constructed by WS Bio on the 14 acre site owned by Zurex at POIC Lahad Datu in Sabah, Malaysia.

The fixed value of the Contract is RM7.28 million (approximately £1.3 million at the current exchange rate), of which 30 per cent (the "Initial Payment") is payable within seven (7) days from the date of the Contract and the balance in the form of a full irrevocable and confirmed letter of credit ("LC") in favour of WS Bio, which WS Bio is entitled to present for payment upon presentation by WS Bio of complete shipping documents in respect of the machinery, equipment and items to be supplied by WS Bio as part of the Refining System under the Contract. WS Bio is required to complete the supply of the Refining System within eight (8) months of receipt of the Initial Payment and the LC. 

WS Bio is also the turnkey contractor for the construction and commissioning of the Refinery and the directors of Biofutures consider that the award of the Contract to WS Bio will lead to an effective and coordinated implementation of the entire project.

Yong Khai Weng is a director of both WS Bio and Zurex (although he is not a director of Biofutures) and, accordingly, the Contract represents a related party transaction for the purposes of the AIM Rules. The directors of Biofutures consider, having consulted with Blomfield Corporate Finance Limited, the Company's AIM nominated adviser, that the terms of the Contract are fair and reasonable insofar as the shareholders of the Company are concerned.

Biofutures is also pleased to announce that Zurex has been offered a bank facility by Bank Kerjasama Rakyat Malaysia Bhd., a licensed bank in Malaysia, for the aggregate sum of up to RM47 million (approximately £8.3 million at the current exchange rate) consisting of two tranches, of which RM28.8 million is for capital expenditure and RM18.2 million for working capital. All remaining conditions precedent as imposed by the bank can be met and Biofutures expects to be able to drawdown soon. 

The Board now considers that the refinery plant will not be operational until 30 September 2010, such delay being attributable to the negotiations and commencement of arbitration proceedings with JJ-Lurgi Engineering Sdn Bhd and the time taken to agree the bank facility against the backdrop of the current difficult economic environment.

The total cost to build the refinery plant, including this Contract, is expected to be between RM38 million and RM40 million. This is in addition to the costs that had been incurred prior to the cessation of the biodiesel project.

For further information please contact:

Enquiries:

Julie Pomeroy, Finance Director

Biofutures International plc

Tel: 07747 624 199

Derek Crowhurst

Blomfield Corporate Finance Limited

Tel: 020 7444 0800

Daniel Briggs

Religare Hichens, Harrison plc

Tel: 020 7444 0500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTTMBITMMTBBJL
Date   Source Headline
5th Dec 20062:39 pmRNSHolding(s) in Company
1st Dec 20062:48 pmRNSHolding(s) in Company
30th Nov 20069:20 amRNSHolding(s) in Company
29th Nov 200612:07 pmRNSHolding(s) in Company
23rd Nov 20061:43 pmRNSEGM Statement
21st Nov 20067:00 amRNSChange of Registered Address
2nd Nov 200612:33 pmRNSDirector/PDMR Shareholding
1st Nov 20062:10 pmRNSDirector/PDMR Shareholding
1st Nov 200611:40 amRNSSchedule 1 - Biofutures Int
30th Oct 20067:01 amRNSAcquisition
30th Oct 20067:01 amRNSRestoration - Biofutures Intl
22nd Sep 20067:00 amRNSMaiden Interim Results
25th Aug 20063:00 pmRNSAppt. of Finance Director
28th Jul 20062:43 pmRNSConditional Agreement
19th Jun 20069:56 amRNSHolding(s) in Company
1st Jun 200611:45 amRNSSuspension - Biofutures Intl
1st Jun 200611:45 amRNSre Press Speculation
24th May 20063:08 pmRNSHolding(s) in Company
24th May 20067:01 amRNSHolding(s) in Company
17th May 20062:45 pmRNSHolding(s) in Company
17th May 200610:19 amRNSHolding(s) in Company
15th May 200611:38 amRNSHolding(s) in Company
15th May 200610:56 amRNSHolding(s) in Company
11th May 200612:10 pmRNSHolding(s) in Company
5th May 20061:39 pmRNSDirector shareholding
5th May 200611:10 amRNSHolding(s) in Company
5th May 20069:00 amRNSPlacing & Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.